Prometheus Biosciences, Inc. RXDX
Set alert
199.92 0.00 0.00%
At close · Jun 15
199.92 Day range 199.96
52-week range unavailable
- Open
- 199.68
- Prev close
- 199.92
- Mkt cap
- 9.56B
- Vol
- 1.79M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 199.92
- High
- 199.96
- Forward P/E
- -44.33
- Beta
- -0.49
- Short ratio
- 3.97
- Inst. own
- 81.01%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 10, 2023
- 50-d avg
- 189.46
- 200-d avg
- 112.93
- 1y target
- 190.00
Financial health
Altman Z-Score
94.08 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -31.5×
FY 2014 5y median -22.4× FY 2022
P/S 656×
FY 2014 5y median 610× FY 2022
P/B 6.6×
FY 2014 5y median 5.3× FY 2022
P/FCF -35.5×
FY 2014 5y median -31.0× FY 2022
EV/EBITDA -29.0×
FY 2014 5y median -28.7× FY 2022
EV/Sales 618×
FY 2014 5y median 606× FY 2022
FCF Yield -2.8%
FY 2014 5y median -3.2% FY 2022
Profitability
Gross Margin 100.0%
FY 2014 5y median 100.0% FY 2022
Operating Margin -2141.0%
FY 2014 5y median -2141.0% FY 2022
Net Margin -2081.8%
FY 2014 5y median -2727.5% FY 2022
ROE -21.0%
FY 2014 5y median -21.0% FY 2022
ROIC -20.2%
FY 2014 5y median -51.1% FY 2022
ROA -19.1%
FY 2014 5y median -60.4% FY 2022
Growth (YoY)
Revenue 117.6%
FY 2014 FY 2022
Operating Income -66.0%
FY 2014 FY 2022
EPS (diluted) -21.6%
FY 2014 FY 2022
Free Cash Flow -94.9%
FY 2014 FY 2022
Financial Health
Current Ratio 31.0×
FY 2014 5y median 6.4× FY 2022
Quick Ratio 31.1×
FY 2014 5y median 6.4× FY 2022
Debt / Equity 0.0×
FY 2014 5y median 0.0× FY 2022
Net Debt / EBITDA 1.8×
FY 2014 5y median 1.6× FY 2022
Interest Coverage 0.0×
FY 2014 5y median -20.7× FY 2022
Dividends
Dividend Yield 0.0%
FY 2014 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2014 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31